Table 1

 Haemodynamic data, histopathology, and weight ratios according to peroxisome proliferator activated receptor γ treatment in rats with and without experimental autoimmune myocarditis (EAM)

GroupNoHW:BW (mg/g)HR (beats/min)SBP(mm Hg)DBP(mm Hg)Pericardial effusion scoreMicroscopic scoreMacroscopic score
Data are mean (SD).
*p<0.05, **p<0.01 v Myocarditis rats.
15d-PGJ2, rats with EAM treated with 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2); Con-15d-PGJ2, normal rats treated with 15d-PGJ2; Con-PIO, normal rats treated with pioglitazone (PIO); Controls, normal rats treated with phosphate buffered saline (PBS); Con-Vehicle, normal rats treated with vehicle; DBP, diastolic blood pressure; HR, heart rate; HW:BW, ratio of heart weight to body weight; Myocarditis, rats with EAM treated with PBS; PIO, rats with EAM treated with PIO; SBP; systolic blood pressure.
Healthy control rats
Con-Vehicle72.98 (0.22)391 (13)130.3 (9.8)91.9 (8.7)000
Con-15d-PGJ273.05 (0.14)411 (24)131.1 (11.1)92.7 (10.2)000
Con-PIO73.09 (0.09)403 (21)132.5 (10.2)90.8 (9.8)000
Experiment I
Controls72.99 (0.11)**401 (20)132.5 (11.7)92.8 (9.1)000
Myocarditis85.45 (0.57)432 (49)131.3 (10.7)91.5 (12.801.8 (0.4)3.4 (0.9)3.5 (1.1)
15d-PGJ284.07 (0.69)**417 (31)131.8 (18.7)91.9 (16.9)0.9 (0.4)**1.5 (0.8)**1.8 (0.7)**
PIO84.19 (1.03)**412 (39)133.2 (13.8)92.8 (15.2)1.2 (0.8)*1.9 (0.8)**2.0 (0.3)**
Experiment II
Controls73.07 (0.13)**396 (31)133.5 (10.7)93.1 (10.2)000
Myocarditis85.56 (0.59)441 (59)129.3 (11.1)91.1 (13.2)1.9 (0.5)3.5 (1.0)3.6 (0.8)
15d-PGJ284.41 (0.38)**427 (61)130.1 (12.7)92.0 (14.7)1.2 (0.7)*2.4 (0.7)*2.3 (0.6)**
PIO84.57 (0.63)*422 (49)131.2 (15.8)91.9 (16.1)1.3 (0.5)*2.7 (0.8)2.6 (0.4)**